| __timestamp | Bristol-Myers Squibb Company | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 305409000 |
| Thursday, January 1, 2015 | 5001000000 | 377080000 |
| Friday, January 1, 2016 | 5002000000 | 432829000 |
| Sunday, January 1, 2017 | 4849000000 | 496079000 |
| Monday, January 1, 2018 | 4551000000 | 557616000 |
| Tuesday, January 1, 2019 | 4871000000 | 658498000 |
| Wednesday, January 1, 2020 | 7661000000 | 770456000 |
| Friday, January 1, 2021 | 7690000000 | 840100000 |
| Saturday, January 1, 2022 | 7814000000 | 944700000 |
| Sunday, January 1, 2023 | 7772000000 | 1136600000 |
| Monday, January 1, 2024 | 8414000000 | 1464300000 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. From 2014 to 2023, Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated have shown contrasting approaches to SG&A cost management. Bristol-Myers Squibb, a stalwart in the industry, has seen its SG&A expenses grow by approximately 36%, peaking in 2022. In contrast, Vertex Pharmaceuticals, known for its innovative treatments, has managed a more modest increase of around 272% over the same period, reflecting its rapid growth and expansion.
While Bristol-Myers Squibb's expenses are significantly higher, Vertex's efficient cost management relative to its size highlights its strategic focus on lean operations. This comparison underscores the diverse strategies employed by pharmaceutical companies in balancing growth with cost efficiency, offering valuable insights into their operational priorities.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.